Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?
about
Development of anticancer agents targeting the Wnt/β-catenin signalingRegulation of Wnt/β-catenin signaling by herpesvirusesThe Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.Can we safely target the WNT pathway?Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patientsSystemic sclerosis-associated fibrosis: an accelerated aging phenotype?Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.A potent peptide as adiponectin receptor 1 agonist to against fibrosis.Wnt signaling, a novel pathway regulating blood pressure? State of the art review.Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin.Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.Role of integrin signalling through integrin-linked kinase in skin physiology and pathology.p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis.
P2860
Q26781898-32F5BEFB-4672-4416-B9A1-1A1601DBA600Q28079414-E23A5CC5-AD97-4955-AD1A-0C0FB4E75A2DQ34670501-51B2AC59-1BC1-46C0-9E9F-6600BA21DB25Q35171136-91D97EF8-FA3E-4388-A25F-EACC6A9596E0Q35591995-FA85AA15-4EDD-4B16-BA14-1034609F577DQ36541005-7682C454-185A-4766-91FD-169B97EDB4A2Q37648637-411C40A2-9DB8-438B-B29B-05FA23634CA8Q38591535-F564FF64-8FF3-49F3-8D60-E59C149DD048Q38649653-46DA439A-BD64-43B6-AC5B-17E2D84FE167Q38929057-23BFF647-9220-4308-AF95-2C5BEC34DB85Q39316445-89F85049-C0A0-4B2F-BA94-0C4A18015371Q41017671-C4FE9E12-8028-4AD9-8DF2-07FC0C43565CQ46491430-28C5522C-46E6-4F41-B011-3EC70A04B6D3Q47109594-A0F60470-0416-4865-876D-4EA904873898Q47117290-A4905486-A5D6-4091-852B-D1610E6EE53FQ47282821-D58E8217-E26C-49E8-9671-CF25F62353BBQ54356684-4863F5BC-3DE9-442D-825A-B4B56C1AB579Q55358970-C393926F-0704-497B-AB02-77261BFAB088
P2860
Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Canonical Wnt signalling as a ...... ations for targeted therapies?
@en
type
label
Canonical Wnt signalling as a ...... ations for targeted therapies?
@en
prefLabel
Canonical Wnt signalling as a ...... ations for targeted therapies?
@en
P2860
P356
P1476
Canonical Wnt signalling as a ...... ations for targeted therapies?
@en
P2093
Clara Dees
Jörg H W Distler
P2860
P304
P356
10.1111/EXD.12255
P577
2013-11-01T00:00:00Z